GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

World Cancer Day ministerial briefing in Abuja, on Tuesday.… WHO Reaffirms Support To Nigeria’s Control Efforts LAGOS – In a renewed move to enhance cancer care in Nigeria, the Federal Govern­ment has ...

James Ketcherside approached the bushes behind the Las Cruces fire station where the woman had been spending nights, bracing ...

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

The Philadelphia Department of Public Health has released its 2023 Annual Report on Hepatitis B, C, and D in the city. The ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

From hepatitis to scabies and food poisoning — the war has caused countless devastating, and often deadly, ailments.

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system. Understanding how 'c-Rel' ...

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

A discovery about the mechanisms that enable the immune system to sustain long-term protection could revolutionize treatment for chronic disease and cancer.

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...